{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:02:59Z","timestamp":1780358579076,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bcmd.2014.04.006","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T08:30:16Z","timestamp":1400315416000},"page":"164-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Combination of deferasirox and deferoxamine in clinical practice: An alternative scheme of chelation in thalassemia major patients"],"prefix":"10.1016","volume":"53","author":[{"given":"E.","family":"Cassinerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Orofino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Roghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Duca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Poggiali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fraquelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zanaboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2014.04.006_bb0005","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatment in \u03b2-thalassemia major: a consensus statement from the American Heart Association, Circulation (2013) 128 281\u2013308","volume":"128","author":"Pennell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2014.04.006_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00277-012-1588-x","article-title":"Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy","volume":"92","author":"Porter","year":"2013","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2014.04.006_bb0015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1182\/blood-2010-11-316646","article-title":"Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5years' follow-up","volume":"118","author":"Cappellini","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.04.006_bb0020","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3324\/haematol.2011.049957","article-title":"Deferasirox for up to 3years leads to continued improvement of myocardial T2* in patients with \u03b2-thalassemia major","volume":"97","author":"Pennell","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bcmd.2014.04.006_bb0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bcmd.2010.05.005","article-title":"Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone","volume":"45","author":"Lai","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.bcmd.2014.04.006_bb0030","article-title":"Combination therapy of deferasirox and deferoxamine shows improvements in markers of iron overload in a patient with beta-thalassemia major and severe iron burden","author":"Voskaridou","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.bcmd.2014.04.006_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3324\/haematol.2012.070607","article-title":"Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine","volume":"98","author":"Grady","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2014.04.006_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bcmd.2012.10.006","article-title":"Combined chelation therapy with deferasirox and deferoxamine in thalassemia","volume":"50","author":"Lal","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2014.04.006_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000174757","article-title":"Safety and efficacy of combined chelation therapy with deferasirox and deferoxamine in a gerbil model of iron overload","volume":"120","author":"Otto-Duessel","year":"2008","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bcmd.2014.04.006_bb0050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MPH.0b013e3181e015b0","article-title":"Retrospective study on the combination of desferrioxamine and deferasirox for treatment of iron-overloaded thalassemic patients: first evidence of more than 2years","volume":"32","author":"Jetsrisuparb","year":"2010","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2014.04.006_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trsl.2010.05.002","article-title":"Mechanism for the shuttling of plasma non-transferrin-bound-iron (NTBI) onto deferoxamine by deferiprone","volume":"156","author":"Evans","year":"2010","journal-title":"Transl. Res."},{"key":"10.1016\/j.bcmd.2014.04.006_bb0060","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2006-05-020867","article-title":"Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences","volume":"108","author":"Glickstein","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.04.006_bb0065","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2004-10-3982","article-title":"MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle-cells disease patients","volume":"106","author":"Wood","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.04.006_bb0070","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/gut.2006.111302","article-title":"Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease","volume":"56","author":"Fraquelli","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.bcmd.2014.04.006_bb0075","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1161\/CIRCULATIONAHA.109.907196","article-title":"History and current impact of cardiac magnetic resonance imaging on the management of iron overload","volume":"120","author":"Wood","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2014.04.006_bb0080","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis","volume":"107","author":"Pennell","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.04.006_bb0085","first-page":"736","article-title":"Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction","volume":"126","author":"Tanner","year":"2008","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.bcmd.2014.04.006_bb0090","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2141.2011.08626.x","article-title":"Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies","volume":"154","author":"Voskaridou","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2014.04.006_bb0095","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/j.gastro.2011.06.065","article-title":"Improvement in liver pathology of patients with \u03b2-thalassemia treated with deferasirox for at least 3years","volume":"141","author":"Deugnier","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:30:07Z","timestamp":1761049807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979614000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1079979614000345"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.04.006","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of deferasirox and deferoxamine in clinical practice: An alternative scheme of chelation in thalassemia major patients","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}